Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Intensity modulated radiation therapy (IMRT) aims to lower radiation-related toxicity by delivering more conformal radiation therapy compared with 3-dimensional conformal radiation therapy (3D-CRT). This study investigated whether IMRT (including volumetric modulated arc therapy) resulted in less acute and late radiation-related toxicity and better treatment compliance compared with 3D-CRT in the phase 3 RAPIDO trial.

Methods And Materials: Patients with locally advanced rectal cancer (LARC), treated with short-course radiation therapy followed by consolidation therapy (total neoadjuvant treatment [TNT] arm) or chemoradiation therapy with optional postoperative chemotherapy (CRT arm) were included. IMRT was compared with 3D-CRT, stratified by treatment arm. Acute, late, and persistent toxicity endpoints included radiation-related gastrointestinal, general, genitourinary, hematologic, and sexual adverse events (CTCAEv4). Toxicity endpoints were analyzed as binary outcomes (grade ≥ 1 vs grade 0 and grade ≥ 3 vs grade 0-2) with univariable and multivariable logistic regression analyses.

Results: For acute and late toxicity analyses, 460 and 352 patients were eligible in the TNT arm, respectively, and 441 and 321 patients in the CRT arm. IMRT was delivered in 29% of the patients. After IMRT in the TNT arm, more acute fatigue grade ≥ 1 (OR, 2.71; 95% CI, 1.60-4.60; P < .001) and more acute nausea/vomiting grade ≥1 (OR, 1.79; 95% CI, 1.15-2.79; P = .010) was observed compared with 3D-CRT. After IMRT in the CRT arm, more any late radiation-related toxicity grade ≥ 1 (OR, 2.14; 95% CI, 1.28-3.57; P = .004) and more late sexual toxicity grade ≥ 1 (OR, 2.31; 95% CI, 1.24-4.29; P = .008) was observed compared with 3D-CRT. No differences were found for other grade ≥ 1 toxicity endpoints, grade ≥ 3 toxicity, or treatment compliance. Persistent toxicity was rare in both groups.

Conclusions: IMRT was not associated with less radiation-related toxicity compared with 3D-CRT after TNT or CRT. In contrast, some lower grade toxicities were more frequent after IMRT, in particular fatigue during TNT. Late persistent toxicity was uncommon in both groups.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2025.04.035DOI Listing

Publication Analysis

Top Keywords

grade ≥
28
radiation therapy
24
radiation-related toxicity
20
compared 3d-crt
20
acute late
16
toxicity
13
late radiation-related
12
conformal radiation
12
crt arm
12
persistent toxicity
12

Similar Publications

Vinorelbine With or Without Thiotepa for HER2-Negative Metastatic Breast Cancer: A Propensity Score Analysis.

Cancer Med

August 2025

Department of Medical Oncology, Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Institut Universitaire de Cancérologie, CLIP2 Galilée, Pitié-Salpêtrière Hospital, Paris, France.

Background: Vinorelbine is commonly used to treat metastatic breast cancer (mBC), while thiotepa is known for its ability to cross the blood-brain barrier.

Methods: Our retrospective study aimed to compare the efficacy and safety of vinorelbine with or without thiotepa in patients with HER2-negative mBC. We used propensity score inverse probability of treatment weighting to ensure comparability between groups.

View Article and Find Full Text PDF

Background: Metastatic esophageal squamous cell carcinoma (mESCC) patients with disease progression after platinum-based first-line chemotherapy (CT) +/- immune checkpoint inhibitors (ICI) may benefit from second-line CT, mostly based on paclitaxel and irinotecan, but no randomized trial has compared these regimens.

Patients And Methods: PRODIGE 62-OESIRI is a multicenter, open-label, randomized phase II trial evaluating the efficacy and safety of nanoliposomal irinotecan (Nal-IRI) plus 5FU versus paclitaxel as second-line CT in mESCC. The primary endpoint was to achieve overall survival (OS) of 60 % at 9 months.

View Article and Find Full Text PDF

Introduction: The MemoKath™-051 (MK) is a thermo-expandable spiral stent for the treatment of benign or malignant ureteral obstruction. Existing studies on outcome measurements, like complication rate or time to stent exchange for MK differ significantly. In this retrospective analysis, we investigated the supposed superiority of the MK over conventional tumor ureteral stent (TUS) insertion.

View Article and Find Full Text PDF

Introduction And Importance: The most prevalent malignant bone tumor that typically impacts young adults is osteosarcoma. Synchronous multifocal osteosarcoma (SMOS) with metastasis is extremely rare, defined by the occurrence of various bone lesions being presented at the time of diagnosis. This report describes a rare case of SMOS with adrenal involvement and a simultaneous abdominal aortic aneurysm (AAA).

View Article and Find Full Text PDF

Background: Peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-DOTA-TATE is an established treatment for advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs). While overall renal safety is high, the kidneys remain an organ at risk. This study aimed to determine whether clinical parameters can predict the risk of PRRT-associated renal function decline.

View Article and Find Full Text PDF